Acute Porphyria Drug Database

Monograph

J05AR03 - Tenofovir Disoproxil and Emtricitabine
Propably not porphyrinogenic
PNP

Rationale
This combination product contains two substances: tenofovir disoproxil (ATC code: J05A F07) and emtricitabine (ATC code: J05A F09). Both of them are safety classified as Probably not porphyrinogenic (PNP). The classification of the combination is therefore safety classified as Probably not porphyrinogenic (PNP). For more details please refer to the monographs of the two substances.
IPNet drug reports
Uneventful use reported in 1 patient with acute intermittent porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes J05A / J05AR or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Tenofovir / Emtricitabine · Truvada · Valdevon Tenofovir / Emtricitabine · Truvada Truvada Tenofovir / Emtricitabine Ictastan · Tenofovir / Emtricitabine · Truvada Oremten · Tenofovir / Emtricitabine · Truvada Tenofovir / Emtricitabine · Truvada Tenofovir / Emtricitabine · Truvada Tenofovir / Emtricitabine · Truvada Tenofovir / Emtricitabine · Truvada Tenofovir / Emtricitabine · Truvada Tenofovir / Emtricitabine · Truvada Gilestra · Tenofovir / Emtricitabine · Truvada
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙